Defining a model to predict the distribution of topically applied growth factors and other solutes in excisional full-thickness wounds.
Controversy over the efficacy of many topical wound treatments, particularly growth factors, is common, with many clinical practitioners still confused as to the real value of these agents. A serious lack of knowledge appears to exist concerning the diffusion and distribution of topically applied solutes in wounds. Without this basic understanding there seems little chance of accurately predicting the therapeutic window of drugs targeted at cellular activities, such as division and chemotaxis, and processes, such as collagen lattice deposition and contraction, occurring below the surface of the granulating layer. This study was designed to determine the absorption and distribution of a number of radiolabeled solutes (water, sodium chloride, lidocaine) and growth factors (basic fibroblast growth factor, epidermal growth factor) applied topically to full-thickness excisional wounds in rats during the early (2 d), mid (7 d), and late (12 d) stages of repair. Results showed that water and sodium penetrated deepest into wound sites and that changes in water distribution and retention in the wound paralleled the healing process. Multiple stepwise regression showed that molecular weight and tissue depth, but not day of healing, were significant factors in predicting the concentration of each solute in wound and underlying tissue sites. This finding was consistent with a tissue diffusion model developed in this study. Basic fibroblast growth factor and epidermal growth factor only penetrated slightly into the upper granulating layers of the wound site, and calculation of therapeutic doses, based on the percentage of applied solute reaching the deeper granulating layers, is presented.
Cross
S E
SE
Department of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
Roberts
M S
MS
D000287:Administration, Topical; D000818:Animals; D004815:Epidermal Growth Factor / Q000493:pharmacokinetics*; D016222:Fibroblast Growth Factor 2 / Q000493:pharmacokinetics*; D006097:Granulation Tissue / Q000378:metabolism; D008954:Models, Biological; D008970:Molecular Weight; D051381:Rats; D012964:Sodium / Q000378:metabolism; D014945:Wound Healing; D014947:Wounds and Injuries / Q000378:metabolism*
D016222:Fibroblast Growth Factor 2; D004815:Epidermal Growth Factor; D012964:Sodium